Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multitarget therapy for prevention of steroid-associated avascular necrosis
IRCT20210808052105N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of atorvastatin, vitamin e and aspirin in osteonecrosis, sponsored by Tehran University of Medical Sciences. Started Feb 2022; status: completed.
02
Drugs
atorvastatinvitamin easpirin
03
Conditions
osteonecrosis
Beyond the preview
Go deeper on IRCT20210808052105N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210808052105N1.